Keros Therapeutics
KROS
$57.72
Share price
2.36%
Change (1 day)
25.29%
Change (1 year)
Categories
Earnings for Keros Therapeutics (KROS)
Earnings in 2023 (TTM): -$0.16 B
According to Keros Therapeutics's latest financial reports the company's current earnings (TTM) are -$0.16 B. In 2022 the company made an earning of -$0.11 B a decrease over its 2021 earnings that were of -$56.73 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Keros Therapeutics from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.16 B | 46.15% |
| 2022 | -$0.11 B | 84.52% |
| 2021 | -$56.73 M | 24.61% |
| 2020 | -$45.53 M | 410.16% |
| 2019 | -$8.93 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -27.59% | 🇺🇸 USA |